Venmax Drugs & Pharmaceuticals Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 5.28 | 2.48 | 4.04 |
| Operating Expense | 5.08 | 2.36 | 3.93 |
| Net Profit | 0.12 | 0.12 | 0.11 |
| Net Profit Margin | 2.27% | 4.84% | 2.72% |
| Earning Per Share | 0.08 | 0.10 | 0.21 |
| EBIDTA | 0.20 | 0.12 | 0.11 |
| Effective Tax Rate | 40% | 0% | 0% |
Particulars
Sep 2026
Revenue5.28
Operating Expense5.08
Net Profit0.12
Net Profit Margin2.27
Earning Per Share0.08
EBIDTA0.20
Effective Tax Rate40
